<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-pharmaceuticals-12-00060">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bardina</surname>
    <given-names>S.V.</given-names>
   </name>
   <name>
    <surname>Bunduc</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tripathi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Duehr</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Frere</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Nachbagauer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Foster</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Krysztof</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Tortorella</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity</article-title>
  <source>Science</source>
  <year>2017</year>
  <volume>356</volume>
  <fpage>175</fpage>
  <lpage>180</lpage>
  <pub-id pub-id-type="doi">10.1126/science.aal4365</pub-id>
  <pub-id pub-id-type="pmid">28360135</pub-id>
 </element-citation>
</ref>
